Leukaemia (lymphocytic) - bendamustine: manufacturer's response to NICE's request for clarification 1

Leukaemia (lymphocytic) - bendamustine: manufacturer's response to NICE's request for clarification 1

Leukaemia (lymphocytic) - bendamustine: manufacturer's response to NICE's request for clarification 1
23 December 2010
(354.34 Kb 43 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 17 December 2010